Caris Life Sciences’ Post

Rapid sample capture and cell preservation is imperative for #clinical researchers to see the full biological complexity of their patient samples anywhere, any time. HIVE CLX™ allows for frequent and scheduled clinical sampling even for sparse and fragile cells. Therefore, HIVE CLX™ is the ideal #singlecell solution for minimally invasive biopsies such as blood draws, nasal swabs, and CSF. Learn more https://hubs.ly/Q024Rr0V0

Powerful Science, powerful results

Yesterday, Dr. Troy Caron was one of the first is the US to treat a patient using OsteoCool 2.0! It’s extremely rewarding to see Medtronics technology improving the quality of life for patients. #MedtronicEmplyoee OsteoCool™ 2.0 radiofrequency ablation (RFA) system — the most powerful metastatic bone tumor ablation system on the U.S. market. OsteoCool™ 2.0 RFA system now supports four internally cooled probes simultaneously, giving physicians options for tailoring the procedure based on tumor characteristics and location - putting patients first with enhanced features specially designed to customize therapy delivery. See risk information: https://bit.ly/3UTMCAG To learn more about OsteoCool™ 2.0 RF ablation system, talk to your Medtronic Representative or read the press release:https://bit.ly/3UTMIIy #MDTPainInterventions #OsteoCool2.0

In this episode, Dr. Costantinos (Costi) Sofocleous, Dr. Bruno Odisio, and Dr. William Rilling discuss the history of percutaneous liver tumor ablation, takeaways from past and present clinical studies, and the contemporary role of ablation margin confirmation software for optimizing treatment outcomes. Full Episode: https://ow.ly/WlBa50QmLIF #LiverAblation #InterventioanalRadiology #AblationConfirmation

In this special issue of #SIUJ featuring Liquid Biopsies in Genitourinary Malignancies, Dr. Roger Li discusses the advantages and challenges of this novel non-invasive method of diagnostic testing. Read the July edition for a deeper look at this topic and much more! #MedTwitter #UroSoMe #OpenAccess #Journal Read the full editorial bit.ly/3QgeUmA Review the latest issue: bit.ly/3kfexdV @UrogerliMD @pcvblack @SpiessPhilippe @LysCampeauMD @jteoh_hk

Come talk with Dr. Michael Salmans today from 1:30 to 5 pm in Poster Section 14 Abstract 323 to learn how the Genece assay design maintains high performance with as low as a 1 ng cfDNA input and variable sequencing depths. Much lower input, and lower cost, than traditional liquid biopsy. #AACR2024

Experience unmatched clarity with the Portrait® CTC staining kit, which uses direct staining and an optimized, vivid dye combination, delivering high signal intensity while maintaining high analytical specificity and sensitivity. Allowing you to confidently identify and enumerate circulating tumor cells (CTCs) and providing insight to enable you to make informed decisions about further downstream analysis. Discover how you can reveal more with the Portrait CTC staining kit and Parsortix technology here: https://lnkd.in/ecYVDZZK #ANGLEplc #Parsortix #CTC #PortraitPlus For Research Use Only. Not For Use in Diagnostic Procedures.

Get the full picture with Invitrogen™ #Attune™CytPix: Advanced, high throughput, acoustic focusing, clog-resistant technology benchtop flow cytometer with up to 14 colors and brightfield imaging capability. Imaging-enhanced #flowcytometry application: 👇Cell-to-cell interactions: Engineered #CART immunotherapy cells were co-incubated with Ramos (lymphoma) cells, stained, acquired, and imaged on the #Attune CytPix Flow Cytometer. Images from quadrant Q2 (positive for both stains, acquired as a single event) show the CAR T cells visibly targeting the Ramos cells, clear evidence of engineered immune cell potency. https://lnkd.in/dqUhxec4 #Cytometry #flowcytometry #Cytpix #cartcelltherapy #immunophenotyping #cancerresearch

The future of diagnosing pre-cancers and dysplasias is a frontier that involves a lot of research and diagnostic technologies. While surgical biopsy remains the gold standard for diagnosing these types of lesions, alternative modalities may become more mainstream in the future. These modalities include enhanced sensors, contrast agents, molecular diagnostics, and even artificial intelligence. They could hold the promose of more effective early diagnosis and thus improved long-term survival. 🌟 Stay ahead in your health journey. Contact us to learn more about the advanced diagnostic options we use at OCI.  To find out more, visit our website: https://lnkd.in/ej3TZrxp  #EarlyDetection #PrecisionMedicine #InnovativeDiagnostics #PreCancerCare #HealthTech #ArtificialIntelligence #MolecularDiagnostics #FutureOfHealthcare